-
Loading metrics
Effectiveness of the Pfizer-BioNTech (BNT162b2) vaccine against the omicron variant of SARS-CoV-2 among adults aged 50 and above: A case-control study in Lebanon, June 2022
- Maryo Baakliny,
- Nada Ghosn,
- Nadine Saleh,
- Patrick Maison
x
- Published: March 20, 2025
- https://doi.org/10.1371/journal.pone.0318344